Veracyte (VCYT) Tops Q2 EPS by 8c, Beats on Revenue; Offers FY24 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St futures muted as oil gains curb risk appetite after S&P record close
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Veracyte Announces Second Quarter 2024 Financial Results
August 6, 2024 4:05 PM EDTGrew total revenue to $114.4 million, an increase of 27%
Grew testing revenue by 31%
Conference call and webcast today at 4:30 p.m. ET
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the second quarter ended June 30, 2024.
Our exceptional second quarter results are a testament to the strength and robustness of Decipher and Afirma, said Marc Stapley, Veracytes chief executive officer. With both tests clearly gaining share in their respective markets and plenty of headroom for... More
